Jongen Christian A M, Heijmen Ben J M, Schillemans Wilco, Zolnay Andras, Witte Marnix G, Pos Floris J, Vanneste Ben, Dubois Ludwig J, van Klaveren David, Incrocci Luca, Heemsbergen Wilma D
Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121,1066 CX Amsterdam, the Netherlands.
Clin Transl Radiat Oncol. 2024 Nov 10;50:100886. doi: 10.1016/j.ctro.2024.100886. eCollection 2025 Jan.
To develop a single NTCP model for grade ≥ 2 late rectal bleeding (G2 LRB) after conventional or hypofractionated radiotherapy for prostate cancer.
The development dataset consisted of prostate cancer patients (n = 656) previously randomized to conventional (39 x 2 Gy) or hypofractionated (19 x 3.4 Gy) external beam radiotherapy with N = 89 G2 LRB cases. Candidate predictors were obtained from literature. We fitted five separate logistic regression models to the data, each with one of the following dose parameters as candidate predictors in biological effective dose (BED), assuming α/β = 3 Gy: Equivalent uniform dose (EUD) with n = 0.1, EUD with n = 0.2, the relative volume receiving ≥ 111.9 Gy in BED (V111.9, the equivalent of physical V70 for a conventional schedule), minimum BED to the hottest 0.1 cm (D) or 2 cm (D). Previous abdominal surgery was included in every model and fractionation schedule was tested as predictor in each model. A sensitivity analysis was performed by varying the α/β-ratio, n and dose-volume cutoff.
The pre-selected candidate dosimetric predictor and previous abdominal surgery were significantly associated with the outcome in all five models. Fractionation schedule was eliminated by the backward scheme in only the EUD (n = 0.1), D and D-based models. In internal validation these models showed AUC's of 0.64, 0.60 & 0.62, respectively. The sensitivity analyses showed that EUD models with n ≥ 0.15 and / or α/β ≥ 4 Gy failed, and EUD models based on α/β = 2 Gy with n = 0.05-0.2 showed good fits as well.
Our trial data set with different fractionation schedules offered the unique possibility to generate unbiased BED-based models. EUD (n = 0.1), D and D performed overall best in predicting G2 LRB; with α/β = 2 Gy equally good models were obtained. External validation is required to confirm our results.
建立一个单一的正常组织并发症概率(NTCP)模型,用于预测前列腺癌患者在接受常规或大分割放疗后发生≥2级晚期直肠出血(G2 LRB)的情况。
开发数据集包括656例前列腺癌患者,这些患者先前被随机分配接受常规(39×2Gy)或大分割(19×3.4Gy)外照射放疗,其中有89例发生G2 LRB。候选预测因子来自文献。我们对数据拟合了五个独立的逻辑回归模型,每个模型将以下剂量参数之一作为生物等效剂量(BED)中的候选预测因子,假设α/β = 3Gy:n = 0.1时的等效均匀剂量(EUD)、n = 0.2时的EUD、接受BED≥111.9Gy的相对体积(V111.9,相当于常规放疗方案中物理剂量的V70)、最热的0.1cm(D)或2cm(D)处的最小BED。每个模型都纳入了既往腹部手术情况,并在每个模型中测试分割方案作为预测因子。通过改变α/β比值、n和剂量体积截止值进行敏感性分析。
在所有五个模型中,预先选择的候选剂量学预测因子和既往腹部手术与结果均显著相关。分割方案仅在EUD(n = 0.1)、D和基于D的模型中通过向后剔除法被排除。在内部验证中,这些模型的曲线下面积(AUC)分别为0.64、0.60和0.62。敏感性分析表明,n≥0.15和/或α/β≥4Gy的EUD模型不适用,基于α/β = 2Gy且n = 0.05 - 0.2的EUD模型拟合效果也较好。
我们的具有不同分割方案的试验数据集为生成无偏倚的基于BED的模型提供了独特的可能性。EUD(n = 0.1)、D和D在预测G2 LRB方面总体表现最佳;α/β = 2Gy时也能获得同样好的模型。需要外部验证来证实我们的结果。